Meiji Yasuda Asset Management Co Ltd. Raises Stake in DaVita Inc. (NYSE:DVA)

Meiji Yasuda Asset Management Co Ltd. lifted its position in DaVita Inc. (NYSE:DVA) by 109.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,642 shares of the company’s stock after purchasing an additional 8,170 shares during the period. Meiji Yasuda Asset Management Co Ltd.’s holdings in DaVita were worth $2,168,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of DVA. Principal Securities Inc. purchased a new stake in DaVita in the 4th quarter worth $37,000. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in DaVita during the 4th quarter valued at approximately $201,000. ING Groep NV lifted its holdings in DaVita by 12,191.7% in the 4th quarter. ING Groep NV now owns 7,375 shares of the company’s stock worth $773,000 after purchasing an additional 7,315 shares in the last quarter. Norges Bank bought a new position in DaVita in the 4th quarter worth approximately $36,626,000. Finally, BI Asset Management Fondsmaeglerselskab A S grew its holdings in DaVita by 899.8% during the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 12,857 shares of the company’s stock valued at $1,347,000 after buying an additional 11,571 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other DaVita news, CEO Javier Rodriguez sold 32,176 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the transaction, the chief executive officer now owns 905,659 shares in the company, valued at $141,219,407.87. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other DaVita news, CFO Joel Ackerman sold 64,029 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total value of $9,928,336.74. Following the completion of the sale, the chief financial officer now owns 111,481 shares of the company’s stock, valued at $17,286,243.86. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Javier Rodriguez sold 32,176 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $155.93, for a total value of $5,017,203.68. Following the transaction, the chief executive officer now directly owns 905,659 shares in the company, valued at approximately $141,219,407.87. The disclosure for this sale can be found here. Insiders sold a total of 173,482 shares of company stock worth $27,387,069 over the last three months. 2.00% of the stock is owned by insiders.

DaVita Stock Down 0.6 %

Shares of NYSE:DVA opened at $163.16 on Thursday. The company has a market cap of $14.31 billion, a price-to-earnings ratio of 18.54, a PEG ratio of 0.95 and a beta of 0.87. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $166.04. The company has a current ratio of 1.16, a quick ratio of 1.12 and a debt-to-equity ratio of 9.94. The company has a 50-day moving average price of $146.25 and a 200 day moving average price of $140.54.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.47 by $0.12. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period last year, the company earned $2.08 EPS. As a group, equities research analysts predict that DaVita Inc. will post 9.99 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently weighed in on DVA. Bank of America upped their target price on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. TD Cowen raised their price objective on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. StockNews.com cut DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. Truist Financial increased their price target on DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a research note on Tuesday, August 20th. Finally, UBS Group lifted their price objective on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $157.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.